The latest survey shows that the overall number of people with diabetes in China is more than 93 million, of which more than 92% are type 2 diabetes. Currently, type 2 diabetic patients face 3 major problems in treatment: 1) low glycemic compliance rate 2) poor compliance with long-term medication 3) multiple cardiovascular disease risk factors are not easily controlled. These 3 problems are related to the arbitrariness of the treatment plan and the blindness of the treatment process. Arbitrariness is the result of the traditional pathway used by physicians in the development and implementation of treatment plans. Blindness is the result of patients following the traditional pathway in the treatment process. The traditional pathway is the personal pathway of each physician, and different regions, different hospitals, different treatment groups, and even different physicians may use different treatment plans for different patients with the same disease. The traditional pathway is apparently “tailored to the individual”, but the individual physicians have different skill levels, specialties, and practice environments, so the guidance and treatment given by the physicians under the traditional pathway is highly arbitrary. It is difficult for patients to identify the best solution, so the implementation of medical advice is also very blind. Due to the arbitrariness of physicians and the blind obedience of patients, the diabetes treatment plan under the traditional pathway is disorganized, lacks supervision, and is difficult to adhere to, so it is difficult to crack the three major problems faced in the treatment of type 2 diabetes patients with the traditional pathway. Clinical pathway is a new clinical management tool to improve the clinical process, which refers to the optimal treatment and care measures given to patients by medical personnel in a chronological order for a disease in a standardized manner. Clinical pathways have been piloted in China for less than a year, and no clinical pathways combining Chinese and Western medicine in type 2 diabetes have been reported. We intend to make full use of the clinical pathway tool, firstly, to reflect the Chinese medicine diagnosis and treatment techniques and Western medicine treatment techniques through the clinical pathway form; secondly, to link the specialist inpatient treatment and general practice home treatment through the clinical pathway form. On the one hand, the pathway establishes and formulates special pathway forms, education programs, patient surveys, focus questions, independent observations, and standardized norms for type 2 diabetes, and on the other hand, the pathway connects specialists and general practitioners with patients to establish a seamless secondary prevention and treatment network. On the other hand, we will strengthen the implementation of out-of-hospital medical advice and reduce the blindness of medical advice implementation. Through the establishment of clinical pathways, the treatment of type 2 diabetes patients can achieve the goals of accurate medication, effective supervision and long-term adherence, providing solutions to the three major problems faced in the treatment of type 2 diabetes patients.